The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
Open accessAbstract
To test the hypothesis that obesity/insulin resistance impairs both endothelium-dependent vasodilation and insulin-mediated augmentation of endothelium-dependent vasodilation, we studied leg blood flow (LBF) responses to graded intrafemoral artery infusions of methacholine chloride (MCh) or sodium nitroprusside (SNP) during saline infusion and euglycemic hyperinsulinemia in lean insulin-sensitive controls (C), in obese insulin-resistant subjects (OB), and in subjects with non-insulin-dependent diabetes mellitus (NIDDM). MCh induced increments in LBF were approximately 40% and 55% lower in OB and NIDDM, respectively, as compared with C (P < 0.05). Euglycemic hyperinsulinemia augmented the LBF response to MCh by - 50% in C (P < 0.05 vs saline) but not in OB and NIDDM. SNP caused comparable increments in LBF in all groups. Regression analysis revealed a significant inverse correlation between the maximal LBF change in response to MCh and body fat content. Thus, obesity/insulin resistance is associated with (a) blunted endothelium-dependent, but normal endothelium-independent vasodilation and (b) failure of euglycemic hyperinsulinemia to augment endothelium-dependent vasodilation. Therefore, obese/insulin-resistant subjects are characterized by endothelial dysfunction and endothelial resistance to insulin's effect on enhancement of endothelium-dependent vasodilation. This endothelial dysfunction could contribute to the increased risk of atherosclerosis in obese insulin-resistant subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, IR per se has a direct impact on endothelial function, distinct from effects related to unfavorable changes in lipid composition or blood pressure (9).”
From Improved Endothelial Function With Metformin in Type 2 Diabetes Mellitus (2001) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Kumar, M. V. J., & Chippada, A. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,366
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. S., & Baron, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,216
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11367.x · Cited by 1,158
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,117
Flagged first, then by citations
Research works printed but not linked: 1
- Brozek, J., and A. Henschel. 1961. Techniques for measuring body com- position: proceedings of a conference. In Conference on Techniques for Mea- suring Body Composition. National Academy of Sciences, National Research Council. Washington DC. 78-89.
Cited by
Sorted by citations
Items 201–300 of 1,001
Early Upregulation of Endothelial Adhesion Molecules in Obese Hypertensive Men
Ferri, C., Desideri, G., Valenti, M., Bellini, C., Pasin, M., Santucci, A., & Mattia, G. D. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.568 · Cited by 165
Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals
Quiñones, M. J., Hernandez‐Pampaloni, M., Schelbert, H., Bulnes‐Enriquez, I., Jimenez, X., Hernandez, G., Rosa, R. D. L., Chon, Y., Yang, H., Nicholas, S. B., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-9-200405040-00009 · Cited by 163
“Type 2 diabetes mellitus is reported to be associated with increased resting myocardial blood flow (3, 4, 21, 22), and, in 1 study, a slightly increased myocardial blood flow at baseline was associated with a paradoxical flow decrease in response to cold pressor test (22).”
BackgroundSuzuki, T., Hirata, K., Elkind, M. S. V., Jin, Z., Rundek, T., Miyake, Y., Boden-Albala, B. M., Tullio, M. R. D., Sacco, R. L., & Homma, S. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.02.022 · Cited by 161
Type 2 Diabetic Individuals Have Impaired Leg Blood Flow Responses to Exercise
Kingwell, B. A., Formosa, M. F., Muhlmann, M. H., Bradley, S. J., & McConell, G. K. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.899 · Cited by 161
“T ype 2 diabetic individuals have impaired dilatory responses to endothelium-dependent agonists such as acetylcholine (1) and methacholine (2,3).”
BackgroundCardiometabolic syndrome: Pathophysiology and treatment
Castro, J. P., El-Atat, F. A., McFarlane, S. I., Aneja, A., & Sowers, J. R. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0085-y · Cited by 161
“This is exemplified by studies that have demonstrated that the compensatory vasodilation seen following relief from prolonged ischemia or infusion of vasodilators such as nitroglycerin is blunted in people with microalbuminuria [ 24 ].”
BackgroundInfluentialMather, K. J., Lteif, A. A., Steinberg, H. O., & Baron, A. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2060 · Cited by 159
Inducible Nitric Oxide Synthase Has Divergent Effects on Vascular and Metabolic Function in Obesity
Noronha, B., Li, J., Wheatcroft, S. B., Shah, A. M., & Kearney, M. T. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1082 · Cited by 158
“There is compelling evidence that obesity leads to endothelial dysfunction (9,10).”
de Boer, M. P., Meijer, R. I., Wijnstok, N. J., Jonk, A. M., Houben, A. J. H. M., Stehouwer, C. D. A., Smulders, Y. M., Eringa, E. C., & Serné, E. H. (2011) · Microcirculation · doi:10.1111/j.1549-8719.2011.00130.x · Cited by 155
Waist Circumference, Visceral Obesity, and Cardiovascular Risk
Poirier, P., & Després, J. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200305000-00001 · Cited by 158
Nitric Oxide, Atherosclerosis and the Clinical Relevance of Endothelial Dysfunction
Anderson, T. J. (2003) · Heart Failure Reviews · doi:10.1023/a:1022199021949 · Cited by 158
“It is clear that both diabetes and insulin resistance are associated with impaired endothelium-dependent vasodilation [76,170].”
BackgroundEndothelial dysfunction precedes hypertension in diet-induced insulin resistance
Katakam, P. V. G., Ujhelyi, M. R., Hoenig, M. E., & Miller, A. W. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.3.r788 · Cited by 159
Old antihypertensives and new diabetes
Opie, L. H., & Schall, R. (2004) · Journal of Hypertension · doi:10.1097/01.hjh.0000133732.24501.9e · Cited by 157
Sansbury, B. E., Cummins, T. D., Tang, Y., Hellmann, J., Holden, C. R., Harbeson, M. A., Chen, Y., Patel, R. P., Spite, M., Bhatnagar, A., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.266395 · Cited by 156
Kobayasi, R., Akamine, E. H., Davel, A. P., Rodrigues, M. A. M., Carvalho, C. R. D. O., & Rossoni, L. V. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833ca68c · Cited by 157
Frequency of Analgesic Use and Risk of Hypertension Among Men
Forman, J. P. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.4.394 · Cited by 155
Caballero, A. E., Saouaf, R., Lim, S. C., Hamdy, O., Abou-Elenin, K., O'Connor, C., LoGerfo, F. W., Horton, E. S., & Veves, A. (2003) · Metabolism · doi:10.1053/meta.2003.50023 · Cited by 154
PPARγ in the endothelium regulates metabolic responses to high-fat diet in mice
Kanda, T., Brown, J. D., Orasanu, G., Vogel, S., Gonzalez, F. J., Sartoretto, J. L., Michel, T. M., & Plutzky, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36233 · Cited by 160
“In humans, endothelial dysfunction occurs early in the natural history of obesity and diabetes, often preceding frank hyperglycemia (2, 3).”
BackgroundKanaya, A., Wassel, C. L., Mathur, D., Stewart, A., Herrington, D., Budoff, M., Ranpura, V., & Liu, K. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0062 · Cited by 144
Blood-Brain Barriers in Obesity
Rhea, E. M., Salameh, T. S., Logsdon, A. F., Hanson, A. J., Erickson, M. A., & Banks, W. A. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0079-3 · Cited by 166
“population (120,121) and may be associated with changes to”
Assessing Microvascular Function in Humans from a Chronic Disease Perspective
Houben, A. J. H. M., Martens, R. J. H., & Stehouwer, C. D. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017020157 · Cited by 150
“43,121,122 Several mechanisms may be involved in obesity-related MVD. Elevated free fatty acid levels augment skin MVD, 28 and expanded/dysfunctional adipose tissue ( 1 ) releases in fl ammatory signals leading to reduced NO and increased endothelin-1 production; and ( 2 ) leads to changes in…”
BackgroundObesity and cardiovascular risk in children and adolescents
Raj, M. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.91176 · Cited by 153
“[33,34] Vascular endothelial dysfunction is associated with a number of cardiovascular risk factors, including obesity, insulin resistance, and hypertension.[35,36] Increased sympathetic over activity is a probable mechanism by which leptin may increase arterial pressure.”
Enhanced endothelin-1 system activity with overweight and obesity
Weil, B. R., Westby, C. M., Guilder, G. P. V., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00206.2011 · Cited by 147
“Previous studies (1, 36, 45, 49) have demonstrated a reduction in endothelium-dependent vasodilation ( 40%) in the peripheral and coronary circulation of overweight and obese adults that is not limited to muscarinic receptor agonists.”
Teede, H. J., Hutchison, S. K., Zoungas, S., & Meyer, C. (2006) · Endocrine · doi:10.1385/endo:30:1:45 · Cited by 148
Lee, K.-U., Lee, I. K., Han, J., Song, D., Kim, Y., Song, H. S., Kim, H. S., Lee, W. J., Koh, E. H., Song, K., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000170075.73039.5b · Cited by 149
Diabetes and Periodontal Infection: Making the Connection
Southerland, J. H., Taylor, G. W., & Offenbacher, S. (2005) · Clinical Diabetes · doi:10.2337/diaclin.23.4.171 · Cited by 147
Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease
Heine, R. J., & Dekker, J. M. (2002) · Diabetologia · doi:10.1007/s00125-001-0726-0 · Cited by 146
Role of Lipotoxicity in Endothelial Dysfunction
Kim, J., Montagnani, M., Chandrasekran, S., & Quon, M. J. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.012 · Cited by 153
Bonadonna, R. C., Saccomani, M. P., Prato, S. D., Bonora, E., DeFronzo, R. A., & Cobelli, C. (1998) · Circulation · doi:10.1161/01.cir.98.3.234 · Cited by 141
Gestational Diabetes: Implications for Cardiovascular Health
Sullivan, S. D., Umans, J. G., & Ratner, R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-011-0238-3 · Cited by 143
Guerci, B., Böhme, P., Kearney‐Schwartz, A., Zannad, F. M., & Drouin, P. (2001) · PubMed · Cited by 143
Manifestations and mechanisms of myocardial lipotoxicity in obesity
Sletten, A. C., Peterson, L. R., & Schaffer, J. E. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12728 · Cited by 148
Methods for Evaluating Endothelial Function in Humans
Barac, A., Campia, U., & Panza, J. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000259601.38807.a6 · Cited by 145
Inhibition of Platelet-Collagen Interaction
Westerbacka, J., Yki‐Järvinen, H., Turpeinen, A., Rissanen, A., Vehkavaara, S., Syrjälä, M. T., & Lassila, R. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.101546 · Cited by 142
Molnár, J., Yu, S., Mzhavia, N., Pau, C., Chereshnev, I., & Dansky, H. M. (2005) · Circulation Research · doi:10.1161/01.res.0000168634.74330.ed · Cited by 141
Compromised Arterial Function in Human Type 2 Diabetic Patients
Okon, E. B., Chung, A. W. Y., Rauniyar, P., Padilla, E., Tejerina, T., McManus, B. M., Luo, H., & van Breemen, C. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2415 · Cited by 139
“The reduced responsiveness in diabetic individuals to endothelial cell agonists has also been observed in vivo (28,29,42,43).”
BackgroundInsulin resistance and compensatory hyperinsulinemia
Reaven, G. M., & Tsao, P. S. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02982-0 · Cited by 149
“More specifically, there is evidence that smokers are insulin resistant and hyperinsulinemic, as compared with nonsmokers (2–9), and these changes can lead to both the dyslipidemia (10) and endothelial dysfunction (11) shown to be present in smokers.”
Kashyap, S., Roman, L. J., Lamont, J., Masters, B. S. S., Bajaj, M., Suraamornkul, S., Belfort, R., Berria, R., Kellogg, D. L., Liu, Y., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0745 · Cited by 141
Eid, H. M. A., Arnesen, H., Hjerkinn, E. M., Lyberg, T., & Seljeflot, I. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.026 · Cited by 139
Effects of Type II diabetes on capillary hemodynamics in skeletal muscle
Padilla, D. J., McDonough, P., Behnke, B. J., Kano, Y., Hageman, K. S., Musch, T. I., & Poole, D. C. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00290.2006 · Cited by 138
Singer, G., & Granger, N. D. (2007) · Microcirculation · doi:10.1080/10739680701283158 · Cited by 140
“The enhanced ROS production caused by leptin may also account for the impaired endothelium-dependent vasodilatory responses to increased shear [5], insulin [112], and methacholine [95].”
BackgroundGetting the message across: mechanisms of physiological cross talk by adipose tissue
Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M. A., & Yudkin, J. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2009 · Cited by 140
“In obesity, impaired insulin-mediated vasodilatation is a recognized precursor of atherothrombotic vascular disease (7, 244).”
BackgroundHyperlipidaemia in hyperuricaemia and gout
Emmerson, B. T. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.9.509 · Cited by 137
Sasaki, S., Higashi, Y., Nakagawa, K., Kimura, M., Noma, K., Sasaki, S., Hara, K., Matsuura, H., Goto, C., Oshima, T., et al. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02322-6 · Cited by 140
Obesity-related cognitive impairment: The role of endothelial dysfunction
Buie, J. N. J., Watson, L. S., Smith, C. J., & Sims‐Robinson, C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104580 · Cited by 138
Erdös, B., Snipes, J. A., Miller, A. W., & Busija, D. W. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1352 · Cited by 134
Factors affecting post-exercise hypotension in normotensive and hypertensive humans
Forjaz, C. L. M., Tinucci, T., Ortega, K. C., Santaella, D. F., Mion, D., & Negrão, C. E. (2000) · Blood Pressure Monitoring · doi:10.1097/00126097-200010000-00002 · Cited by 134
Traupe, T., Lang, M., Göettsch, W., Münter, K., Morawietz, H., Vetter, W., & Barton, M. (2002) · Journal of Hypertension · doi:10.1097/00004872-200211000-00024 · Cited by 133
Endothelial dysfunction in obesity: etiological role in atherosclerosis
Meyers, M. R., & Gokce, N. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282be90a8 · Cited by 134
Laine, H. K., Yki‐Järvinen, H., Kirvelä, O., Tolvanen, T., Raitakari, M., Solin, O. H., Haaparanta‐Solin, M., Knuuti, J. M., & Nuutila, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1065 · Cited by 135
“In addition to this classic defect in insulin action, the ability of insulin to vasodilate has also been examined in a few studies and has been found to be either blunted (2, 4) or normal (5) in obese subjects.”
BackgroundInfluentialHogikyan, R. V., Gałecki, A. T., Pitt, B., Halter, J. B., Greene, D. A., & Supiano, M. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4907 · Cited by 151
How mental stress affects endothelial function
Toda, N., & Nakanishi-Toda, M. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-1022-6 · Cited by 132
“Impairment of endothelial function plays a key role in the pathogenesis of blood supply deficiency to various organs and tissues including the brain [118], heart [120], and eye [119]; blood pressure elevation [24, 116]; and insulin resistance [113].”
BackgroundNonalcoholic fatty liver disease as a multi-systemic disease
Fotbolcu, H., & Zorlu, E. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i16.4079 · Cited by 129
Cheetham, C., Collis, J. J., O’Driscoll, G., Stanton, K. G., Taylor, R. R., & GREEN, D. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00933-5 · Cited by 129
Cook, S., Hügli, O., Egli, M., Ménard, B., Thalmann, S., Sartori, C. S., Perrin, C., NICOD, P. H., Thorens, B., Vollenweider, P., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2067 · Cited by 130
“In insulin-resistant individuals, insulin stimulation of endothelial NO synthesis is impaired and may contribute to defective skeletal muscle glucose uptake (7).”
BackgroundAllopurinol improves endothelial function in sleep apnoea: a randomised controlled study
Solh, A. A. E., Saliba, R. M., Bosinski, T. J., Grant, B. J. B., Berbary, E., & Miller, N. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00101005 · Cited by 136
Koška, J., Schwartz, E. A., Mullin, M. P., Schwenke, D. C., & Reaven, P. D. (2010) · Diabetes Care · doi:10.2337/dc09-1961 · Cited by 128
“E ndothelial dysfunction frequently occurs in insulin resistance and type 2 diabetes (1) and can be induced by high-fat or high-carbohydrate meals (2).”
BackgroundCeramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo
Bharath, L. P., Ruan, T., Li, Y., Ravindran, A., Wan, X., Nhan, J. K., Walker, M., Deeter, L., Goodrich, R., Johnson, E., et al. (2015) · Diabetes · doi:10.2337/db15-0244 · Cited by 127
Insulin Action in the Vasculature: Physiology and Pathophysiology
Mather, K. J., Anderson, T. J., & Verma, S. (2001) · Journal of Vascular Research · doi:10.1159/000051074 · Cited by 123
“Vascular health is reflected in a balanced production of vasodilators and vasoconstrictors (fig. 1 ). In many diseases, endothelial dysfunction results in impaired production or action of nitric oxide, and therefore the balance of acute and chronic effects is less favorable. Also, the actions of constrictor agents suc…”
Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., Shulman, G. I., McVeety, J. C., & Horwitz, R. I. (2003) · Neurology · doi:10.1212/01.wnl.0000063318.66140.a3 · Cited by 126
Brett, S., Ritter, J. M., & Chowienczyk, P. (2000) · Circulation · doi:10.1161/01.cir.101.6.611 · Cited by 129
Insulin Action Is Associated With Endothelial Function in Hypertension and Type 2 Diabetes
Cleland, S. J., Petrie, J. R., SMALL, M. P., Elliott, H. L., & Connell, J. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.507 · Cited by 125
Higashi, Y. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02191-4 · Cited by 125
Kuşçu, N. K., & Var, A. (2009) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340902859315 · Cited by 125
“Obesity, which was not seen in our study group, was reported as a prominent feature for endothelial dysfunction (28).”
BackgroundLiu, Z., Que, S., Zhou, L., & Zheng, S. (2015) · Scientific Reports · doi:10.1038/srep14325 · Cited by 125
Obesity and risk of vascular disease: importance of endothelium‐dependent vasoconstriction
Barton, M., Baretella, O., & Meyer, M. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01472.x · Cited by 131
“Overweight children prematurely develop abnormal endothelial cell function and thickening of the arterial vascular wall (Woo et al., 2004), as well as myocardial wall thickening (de Jonge et al., 2011), features usually observed only in obese adults or aged individuals (Steinberg et al., 1996).”
BackgroundObesity and Coronary Heart Disease
Alexander, J. K. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200104000-00002 · Cited by 125
Carneiro, G., Faria, A. N., Filho, F. F. R., Guimarães, A., Lerario, D. D. G., Ferreira, S. R. G., & Zanella, M. T. (2003) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302003000300036 · Cited by 123
Virdis, A., Santini, F., Colucci, R., Duranti, E., Salvetti, G., Rugani, I., Segnani, C., Anselmino, M., Bernardini, N., Blandizzi, C., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.050 · Cited by 119
Obesity Is Associated With Tissue-Specific Activation of Renal Angiotensin-Converting Enzyme In Vivo
Barton, M., Carmona, R., Morawietz, H., d’Uscio, L. V., Göettsch, W., Hillen, H., Haudenschild, C. C., Krieger, J. E., Münter, K., Lattmann, T., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.329 · Cited by 122
Human obesity and endothelium‐dependent responsiveness
Campia, U., Tesauro, M., & Cardillo, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01661.x · Cited by 124
“These authors demonstrated a blunted increase of leg blood flow in response to graded intra-arterial doses of the muscarinic receptor agonist methacholine in patients with elevated BMI or type 2 diabetes compared with lean controls (Steinberg et al., 1996).”
BackgroundHuman endothelial dysfunction: EDRFs
Flammer, A. J., & Lüscher, T. F. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0822-4 · Cited by 127
“major cardiovascular risk factors including in arterial hypertension [59, 73], in normotensive individuals with a family history of hypertension [96], in active smokers [17, 116] and passive smokers [18], in dyslipidemia [15, 89], in aging subjects [59], in diabetes mellitus [13, 23, 62, 88, 91], in obesity [91], in h…”
BackgroundMicrocirculation and oxidative stress
Crimi, E., Ignarro, L. J., & Claudio Napoli, A. (2007) · Free Radical Research · doi:10.1080/10715760701732830 · Cited by 123
Hayden, J. M., & Reaven, P. D. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00010 · Cited by 121
Insulin resistance in the vasculature
Mather, K. J., Steinberg, H. O., & Baron, A. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67166 · Cited by 120
“Moreover, in the insulin-resistant states of human obesity and type 2 diabetes, this vascular action of insulin was impaired (2).”
Self-citationHu, X., Sato, J., Oshida, Y., Xu, M., Bajotto, G., & Sato, Y. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00203-6 · Cited by 120
“Previous studies indicated that NO was involved in the regulation of skeletal muscle hemodynamics and it was believed to be an important determinant of glucose utilization through vasodilatation associated with insulin [23].”
BackgroundKraemer‐Aguiar, L. G., Bahia, L. R., Villela, N., Laflor, C., Sicuro, F., Wiernsperger, N., Bottino, D., & Bouskela, E. (2006) · Diabetes Care · doi:10.2337/diacare.2951083 · Cited by 119
“Considering that metformin in diabetic patients has vasculoprotective effects and that endothelial dysfunction is the first manifestation of the atherosclerotic process, which is well established in insulin resistance states (5,7), perhaps early interventions would be of value in subjects at risk of developing type 2…”
BackgroundJiang, Z. Y., Zhou, Q., Chatterjee, A., Feener, E. P., Myers, M. G., White, M. F., & King, G. L. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1120 · Cited by 121
Grassi, G. M., Seravalle, G., Scopelliti, F., Dell’Oro, R., Fattori, L., Quarti‐Trevano, F., Brambilla, G., Schiffrin, E. L., & Mancia, G. (2009) · Obesity · doi:10.1038/oby.2009.195 · Cited by 119
“Thus, in obese persons endothelial dysfunction does not selectively affect large- and medium-size arteries (7,8) but it extends also to the microcirculation as well.”
BackgroundInfluentialDatta, R., Podolsky, M. J., & Atabai, K. (2018) · JCI Insight · doi:10.1172/jci.insight.122289 · Cited by 131
The Endothelium in Health and Disease-A Target for Therapeutic Intervention.
Triggle, C. R., Hollenberg, M. D., Anderson, T. J., Ding, H., Jiang, Y., Ceroni, L., Wiehler, W. B., Ng, E. S. M., Ellis, A., Andrews, K. L., et al. (2003) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.39.249 · Cited by 118
“In addition, it has been shown that endothelial dysfunction occurs in insulin-resistant obese individuals prior to the development of diabetes (Steinberg et al., 1996).”
BackgroundVascular Remodeling after Spinal Cord Injury
Olive, J. L., Dudley, G. A., & McCully, K. K. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000069755.40046.96 · Cited by 119
Scherrer, U., & Sartori, C. S. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420315 · Cited by 117
New insights into insulin action and resistance in the vasculature
Manrique, C. M., Lastra, G., & Sowers, J. R. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12395 · Cited by 121
Eringa, E. C., Bakker, W., Smulders, Y. M., Serné, E. H., Yudkin, J. S., & Stehouwer, C. D. A. (2007) · Microcirculation · doi:10.1080/10739680701303584 · Cited by 116
Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches
Tousoulis, D., Simopoulou, C., Παπαγεωργίου, Ν., Oikonomou, E. K., Hatzis, G., Siasos, G., Tsiamis, E. G., & Stefanadis, C. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.003 · Cited by 120
“Obese individuals with insulin resistance have impaired endothelial function (Steinberg et al., 1996).”
BackgroundSiroen, M. P. C., van Leeuwen, P. A. M., Nijveldt, R. J., Teerlink, T., Wouters, P. J., & den Berghe, G. V. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000155784.59297.50 · Cited by 117
Exercise training, vascular function, and functional capacity in middle-aged subjects
Maiorana, A., Driscoll, G. O., Dembo, L. G., Goodman, C., Taylor, R. R., & GREEN, D. J. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200112000-00008 · Cited by 116
Obesity Exacerbates Oxidative Stress Levels after Acute Exercise
Vincent, H. K., MORGAN, J. W., & Vincent, K. R. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000126576.53038.e9 · Cited by 116
Endothelial dysfunction in type 2 diabetes mellitus
Avogaro, A., Fadini, G. P., Gallo, A., Pagnin, E., & de Kreutzenberg, S. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.015 · Cited by 116
Should we consider gestational diabetes a vascular risk factor?
Bo, S., Valpreda, S., Menato, G., Bardelli, C., Botto, C., Gambino, R., Rabbia, C., Durazzo, M., Cassader, M., Massobrio, M., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.017 · Cited by 117
Muscle metaboreflex control is diminished in normotensive obese women
Negrão, C. E., Trombetta, I. C., Batalha, L. T., Ribeiro, M. M., Rondon, M. U. P. B., Tinucci, T., Forjaz, C. L. M., Barretto, A. C. P., Halpern, A., & Villares, S. M. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.2.h469 · Cited by 116
“Although previous studies have found that the vasodilatation during hyperemia (10) or during euglycemic-hyperinsulinemic condition (22, 23) is impaired in obese individuals, the vasodilatory responses during exercise were not altered in the present study.”
BackgroundSon, W., Sung, K.-D., Cho, J.-M., & Park, S. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000765 · Cited by 122
Birschmann, I., & Walter, U. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3579 · Cited by 115
“Studies with human subjects indicate that hypertension and type 2 diabetes are associated with an impaired vasodilatory response to acetylcholine and SNP, suggesting impaired VSMC responsiveness to NO (Steinberg et al., 1996).”
BackgroundEndothelial dysfunction: role in obesity-related disorders and the early origins of CVD
Singhal, A. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2004404 · Cited by 115
“Furthermore, because the growthretarded fetus is one category of individual that shows faster postnatal growth (while large newborns show growth deceleration) postnatal growth acceleration could also explain previous associations between low birth weight and later cardiovascular risk.”
BackgroundEndothelin Limits Insulin Action in Obese/Insulin-Resistant Humans
Lteif, A. A., Vaishnava, P., Baron, A., & Mather, K. J. (2007) · Diabetes · doi:10.2337/db06-1406 · Cited by 115
“This vascular action of insulin is impaired in states of insulin resistance (9,42,43), and we and others have previously shown that increased endogenous endothelin contributes to vascular dysfunction in obesity and diabetes (7,8).”
BackgroundAlveolar Gas Diffusion Abnormalities in Heart Failure
Guazzi, M. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.06.004 · Cited by 114
Anderssohn, M., Schwedhelm, E., Lüneburg, N., Vasan, R. S., & Böger, R. H. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110366053 · Cited by 114
Obesity-associated activation of angiotensin and endothelin in the cardiovascular system
Barton, M., Carmona, R., Ortmann, J., Krieger, J. E., & Traupe, T. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00307-2 · Cited by 113
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA
Sydow, K., Mondon, C. E., & Cooke, J. P. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000106 · Cited by 114
Caballero, A. E. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0074-9 · Cited by 114
Metadata
- Authors
- Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D.
- Affiliations
- Indiana University (US)
- Richard L. Roudebush VA Medical Center (US)
- Indiana University Hospital (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-06-01
- Volume
- 97
- Issue
- 11
- Pages
- 2601-2610
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507347
- OpenAlex
- W1982811953
- Cited by
- 1,687
- References
- 59
- Citations by year
- 2026: 11 · 2025: 23 · 2024: 17 · 2023: 30 · 2022: 19 · 2021: 32 · 2020: 30 · 2019: 36 · 2018: 36 · 2017: 46 · 2016: 50 · 2015: 51 · 2014: 69 · 2013: 69 · 2012: 61
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- American Heart Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42469, P60DK020542, DK20542)
- National Center for Research Resources (M 01-RR750-19)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- obesity, insulin resistance, endothelial dysfunction, endothelium-dependent vasodilation, euglycemic hyperinsulinemia, leg blood flow, methacholine, sodium nitroprusside, type 2 diabetes, fat mass, atherosclerosis risk
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Cholesterol, Diabetes Mellitus, Type 2, Endothelium, Vascular, Fatty Acids, Nonesterified, Glucose, Humans, Hyperinsulinism, Infusions, Intra-Arterial, Infusions, Intravenous, Insulin, Insulin Resistance, Leg, Cholesterol, HDL, Cholesterol, LDL, Nitroprusside, Obesity, Reference Values, Regional Blood Flow, Syndrome, Time Factors, Triglycerides, Vasodilation, Glucose Clamp Technique, Body Mass Index, Methacholine Chloride
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
